Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Adagio Therapeutics Summarizes ADG20 Neutralizing Activity Against SARS-CoV-2 Variants and Outlines Initiatives to Address Omicron

FirstWordPharmaJanuary 13, 2022

Tag: ADG20 , SARS-CoV-2 Variants , Omicron

PharmaSources Customer Service